Skip to main content
. 2024 Aug 30;27(9):110839. doi: 10.1016/j.isci.2024.110839

Table 2.

Comparison of flow cytometry statistics between recovered and PCC individuals

Variables Recovered (n = 85) PCC (n = 85) p value
CD56+CD16+ cells among NK + NKT, % 63.20 (25.30) 73.45 (28.72) 0.038
CD56+CD16 cells among NK + NKT, % 35.70 (27.00) 23.30 (26.50) 0.032
CD56CD16bright among CD56 cells, % 2.21 (2.22) 1.60 (1.17) <0.001
Naive CD8+ cells among CD8+ cells, % 22.10 (20.73) 29.40 (25.93) 0.023
Effector CD8+ among CD8+ cells, % 16.60 (14.80) 13.15 (12.18) 0.015
CD8+CD4low cells among T lymphocytes % 0.37 (0.39) 0.50 (0.44) 0.013

Subsets of cells in human peripheral blood based on the relative expression of either CD16 and CD56 or CD8 and either CD45RA or CD62L. Frequencies (in %) among CD3CD56+ NK cells, CD56 lymphocytes cells, and CD3+CD8+ cells are indicated for each patient group. Recovered: individuals who completely recovered within 3 months after acute COVID-19; PCC: individuals diagnosed with post-COVID-19 condition; values are presented as median (interquartile range). Statistical differences were calculated using Mann-Whitney’s U-test.